Rocket
Premium
Excel Add-In
International
Tools
Dashboard
Screener
Spinoffs
IPOs
Register
Alerts
Sign In
News + Filings
Transactions
Darvish Nissim
Date
Name
Symbol
Type
Security
Shares
Price
Value
Ownership
Reported
06/14/2023
Chemomab Therapeutics Ltd.
ANCN
Grant
20.6k
$1.70
$35k
06/14/2023
03/16/2023
Chemomab Therapeutics Ltd.
ANCN
Grant
6.9k
$1.62
$11.1k
06/14/2023
03/16/2023
Chemomab Therapeutics Ltd.
ANCN
Grant
6.9k
$1.62
$11.1k
03/16/2023
03/11/2022
Chemomab Therapeutics Ltd.
ANCN
Purchase
1.2k
$4.28
$5.1k
03/11/2022
03/07/2022
Chemomab Therapeutics Ltd.
ANCN
Grant
6.8k
$3.53
$24.1k
03/16/2023
03/07/2022
Chemomab Therapeutics Ltd.
ANCN
Grant
6.8k
$3.53
$24.1k
06/14/2023
03/07/2022
Chemomab Therapeutics Ltd.
ANCN
Grant
Option to Purchase American Depositary Shares
6.8k
$3.53
$24.1k
03/07/2022
03/07/2022
Chemomab Therapeutics Ltd.
ANCN
Grant
6.8k
$3.53
$24.1k
03/11/2022
04/19/2021
Chemomab Therapeutics Ltd.
ANCN
Grant
11.9k
$27.26
$324k
03/07/2022
04/19/2021
Chemomab Therapeutics Ltd.
ANCN
Grant
Option to Purchase American Depositary Shares
11.9k
$27.26
$324k
04/19/2021
04/19/2021
Chemomab Therapeutics Ltd.
ANCN
Grant
11.9k
$27.26
$324k
06/14/2023
04/19/2021
Chemomab Therapeutics Ltd.
ANCN
Grant
11.9k
$27.26
$324k
03/16/2023
04/19/2021
Chemomab Therapeutics Ltd.
ANCN
Grant
11.9k
$27.26
$324k
03/11/2022
03/16/2021
Chemomab Therapeutics Ltd.
ANCN
Grant
10.1k
$0.80
$8.1k
03/11/2022
10/30/2020
9 METERS BIOPHARMA, INC.
INNT
Other (acquisition)
Common stock
1.9M
$0.00
$0
See footnote
10/30/2020
06/30/2020
9 METERS BIOPHARMA, INC.
INNT
Conversion
Series A Convertible Preferred Stock
67.9k
$0.00
$0
See Footnote
06/30/2020
06/30/2020
9 METERS BIOPHARMA, INC.
INNT
Conversion
Common stock
6.8M
$0.00
$0
See footnote 1
06/30/2020
05/04/2020
9 METERS BIOPHARMA, INC.
INNT
Purchase
Series A Convertible Preferred Stock
67.9k
$0.00
$0
See Footnote
05/04/2020
05/04/2020
9 METERS BIOPHARMA, INC.
INNT
Purchase
Series A Convertible Preferred Warrant
67.9k
$0.00
$0
See Footnote
05/04/2020
04/30/2020
9 METERS BIOPHARMA, INC.
INNT
Grant
Stock Option (Right to Buy)
50k
$0.70
$35k
see footnote
04/30/2020
10/28/2016
Chemomab Therapeutics Ltd.
ANCN
Grant
10.1k
$0.80
$8.1k
03/16/2023
10/28/2016
Chemomab Therapeutics Ltd.
ANCN
Grant
10.1k
$0.80
$8.1k
06/14/2023
Rocket Data Systems, Inc. © 2019 |
Contact Us
|
Data Disclaimer
|
Terms of Use
|
Privacy